If you look up the top ten leading causes of death, old age is the No. 1 risk factor for nearly all of them. University of Delaware assistant professor Christopher Martens (Kinesiology and Applied Physiology) is investigating a novel compound’s role in combating age-related chronic diseases like mild cognitive disorder and dementia. He’s interested in treatments that slow the process of aging. In a grant funded by National Institute on Aging, he is studying a naturally occurring dietary supplement, nicotinamide riboside (NR) — a novel form of vitamin B3 — and its efficacy for boosting nicotinamide adenine dinucleotide (NAD+).

“NAD+ is critically involved in just about every metabolic process in our cells,” said Martens, who earned his doctorate from UD before completing post-doctoral training at the University of Colorado Boulder. Read the full article on UDaily